<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke&#x54A8;&#x8BE2;&#x7F51;&#x7AD9;</provider_name><provider_url>https://brakkeconsulting.com/zh</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="52mOL5ZyA4"&gt;&lt;a href="https://brakkeconsulting.com/zh/23592/"&gt;2000&#x5E74;9&#x6708;15&#x65E5;&#x52A8;&#x7269;&#x5065;&#x5EB7;&#x65B0;&#x95FB;&#x4E0E;&#x7B80;&#x62A5;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/zh/23592/embed/#?secret=52mOL5ZyA4" width="600" height="338" title="&#x300A;2000&#x5E74;9&#x6708;15&#x65E5;&#x52A8;&#x7269;&#x5065;&#x5EB7;&#x65B0;&#x95FB;&#x4E0E;&#x7B80;&#x8BAF;&#x300B;&#x2014;&#x2014;&#x5E03;&#x62C9;&#x514B;&#x54A8;&#x8BE2;&#x516C;&#x53F8;&#x7F51;&#x7AD9;" data-secret="52mOL5ZyA4" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for September 15, 2000 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company News Releases &gt; Intervet introduced PRISIM (Performance Report for Integrating Solutions in Management), a program providing feedlot managers with a comprehensive performance analysis tool.&nbsp; The program includes 20 parameters that allow feedlot managers to predict cattle growth and performance.&nbsp; The program will be licensed to Intervet feedlot customers, beef industry consultants and nutritionists.&nbsp; (Feedstuffs) &gt;&nbsp; Merial announced that it has received approvals from the EPA to market FRONTLINE Plus for Dogs and FRONTLINE Plus for Cats in the United States. These new products combine an adulticide (fipronil) and insect growth regulator (s-methoprene) for complete flea control and broad-spectrum tick protection for dogs and cats.&nbsp; Like other FRONTLINE brand products, FRONTLINE Plus is a spot-on flea and tick preventive.&nbsp; Merial intends to introduce FRONTLINE Plus into other countries around the world as soon as possible, subject to local regulatory approvals. (company website) &gt;&nbsp; Applied Molecular Evolution, Inc. announced that it has granted a non-exclusive sublicense to IDEXX Laboratories, Inc. for Applied Molecular Evolution&rsquo;s (AME&rsquo;s) Kauffman patents for directed evolution.&nbsp; IDEXX plans to use the Kauffman patents to develop diagnostic applications. The Kauffman patent family comprises six issued U.S. patents with claims covering methods of stochastically generating proteins, which AME believes is requiredView Full Post;</description></oembed>
